Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

about

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

Item

http://www.wikidata.org/entity/Q49547342

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@en

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@nl

type

Item

label

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@en

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@nl

prefLabel

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@en

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@nl

P1476

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.

@en

P2093

Agnieszka K Witkiewicz

http://www.w3.org/2001/XMLSchema#string

Erik S Knudsen

http://www.w3.org/2001/XMLSchema#string

Jorge Franco

http://www.w3.org/2001/XMLSchema#string

Paris Vail

http://www.w3.org/2001/XMLSchema#string

Rachel Brough

http://www.w3.org/2001/XMLSchema#string

Sejin Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

Statistical methods for analysis of high-throughput RNA interference screens

RB1: a prototype tumor suppressor and an enigma

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Targeting CDK4 and CDK6: From Discovery to Therapy

The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design

Triple-Negative Breast Cancer

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.

P304

1185-1199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2018.01.022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J Lord

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29386107

http://www.w3.org/2001/XMLSchema#string

P932

5967622

http://www.w3.org/2001/XMLSchema#string